Stockreport

NovaBay Pharmaceuticals Reports First Quarter 2024 Financial Results [Yahoo! Finance]

NovaBay Pharmaceuticals, Inc.  (NBY) 
NASDAQ:AMEX Investor Relations: novabay.com/investors
PDF Sales and marketing expenses declined 15% reflecting continued digital marketing optimization Ordered product sales for Avenova-branded products on Amazon.com reached [Read more]